Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.21M Buy
+26,187
New +$9.34M 0.95% 9
2025
Q3
Sell
-43,403
Closed -$12.1M 556
2025
Q2
$12.1M Buy
+43,403
New +$12.3M 0.27% 103
2025
Q1
Sell
-5,204
Closed -$1.36M 695
2024
Q4
$1.36M Buy
5,204
+3,335
+178% +$989K 0.02% 359
2024
Q3
$602K Buy
+1,869
New +$611K 0.01% 568
2023
Q2
Sell
-7,773
Closed -$1.88M 577
2023
Q1
$1.88M Buy
+7,773
New +$1.91M 0.04% 382
2022
Q3
Sell
-1,030
Closed -$251K 606
2022
Q2
$251K Buy
+1,030
New +$252K 0.01% 465
2021
Q3
Sell
-9,550
Closed -$2.33M 562
2021
Q2
$2.33M Buy
+9,550
New +$2.35M 0.28% 116

Other funds holding AMGN

TwinBeech Capital's AMGN Position: Q1 2026 in Review

TwinBeech Capital opened a new position in Amgen (AMGN) in Q1 2026: 26,187 shares worth $9.21M. The stake represents 0.95% of the portfolio and ranks #9 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in AMGN as recently as Q2 2025.

TwinBeech Capital first reported a position in AMGN in Q2 2021 and has held it in 7 quarters since. The position peaked at $12.1M in Q2 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • TwinBeech Capital held 26,187 shares of Amgen worth $9.21M as of Q1 2026.
  • Amgen was a new TwinBeech Capital position in Q1 2026.
  • Amgen made up 0.95% of TwinBeech Capital's portfolio in Q1 2026, its #9 holding.
  • TwinBeech Capital first reported a position in Amgen in Q2 2021 and has held it in 7 quarters since.
  • TwinBeech Capital's Amgen position peaked at $12.1M in Q2 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.